CClinicalTrials.gg
Status unknownNCT01955577Updated Apr 10, 2015

Vitamin D Supplement for Patients With Tibial Fracture

A Phase 1 interventional study of Placebo orally everyday and Vitamin D3 cholecalciferol in Tibial Fracture, sponsored by Northern Orthopaedic Division, Denmark. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-04-10.

Sponsored by Northern Orthopaedic Division, Denmark · Phase 1, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2015), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The purpose is to study:

  1. the frequency of vitamin D deficiency at patients with tibial fracture treated with an external ring fixator
  2. if vitamin D supplement facilitates fracture healing
  3. a possible relation between vitamin D deficiency and the risk of complications and the time of fracture healing
Read the detailed description

External ring fixator is a widespread and well-known method to treate complex tibial fractures. The effect of treating proximal and distal intra-articulatio tibial fractures has been positive until now.

Complications such as malunions, nonunions, re-fractures and extended time of ring fixation will occur in 5-10% of all tibial fractures in patients treated with ring fixator. Factors like trauma of soft tissue, smoking and compromised afflux of blood are associated with a higher frequency of nonunion.

It has been documented that elderly people with hypovitaminosis D have a higher risk of being affected by osteoporosis and fractures. Furthermore, there is a possible association between the severity of fracture and hypovitaminosis. The time of fracture healing is also extended compared to fractures in patients who are not affected by osteoporosis.

Until now research has not shown whether the fracture healing process is influenzed by vitamin D.

02

Conditions studied

  • Tibial Fracture

Keywords

  • Vitamin D deficiency
  • Ring fixator
  • Tibial fracture
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 130 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Northern Orthopaedic Division, Denmark is the lead sponsor of 61 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with tibial fracture
  • A written signed statement of consent
  • All potential patients primary with osteosynthesis Iliazov

Exclusion criteria

Exclusion Criteria:

  • Tumours in bone
  • Metastases to bone marrow
  • Chronic renal disease
  • Drug abuse
  • Abuse of alcohol (>21 drinks a week for men and > 14 drinks a week for women)
  • Morbus Cushing disease
  • Glandulae thyroid disease
  • Pregnancy
  • Chronic steroid therapy
  • Hepatic insufficiency
  • Sarcoidosis, tuberculosis or silocosis
  • Patients under 18 years
  • Inability to take medicine
  • Adverse effects of vitamin D or allergic to vitamin D
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Vitamin D3 cholecalciferol

    1000IU x3 daily in a period of 14 days. After 14 days 1000IU x 1 daily.

    Drug: Vitamin D3 cholecalciferol

  • Placebo comparator
    Placebo orally everyday

    One placebo pill x3 daily in a period of 14 days. After 14 days x1 placebo pill daily.

    Drug: Placebo orally everyday

Interventions

  • DrugPlacebo orally everyday
  • DrugVitamin D3 cholecalciferol
06

What researchers measure

Primary outcomes

  1. Time of fracture healing

    Time of fracture healing, i.e. time from osteosynthesis until fracture healing is clinically and radiologically registered.

    Time frame: 20 weeks

Secondary outcomes

  1. Vitamin D receptor DNA

    A DNA blood sample will be taken in order to analyse how the skeleton reacts on vitamin D supplement.

    Time frame: 20 weeks

  2. Complications

    Registration of possible complications, i.e. nonunion, malunion, number of check-ups, infections, re-surgery.

    Time frame: 20 weeks

07

Study locations

1 site
  • Aalborg University Hospital
    Aalborg, Region Northern Jutland 9000, Denmark
    • Tine L. Bennedsen, M.D. · Contact · tilb@rn.dk · 99 32 63 46
    • Juozas Petruskevicius, M.D., Ph.d. · Contact · juope@rn.dk · 99 32 52 40
    • Christian Cavallius, M.D. · Principal investigator
    • Juozas Petruskevicius, M.D., Ph.D. · Sub investigator
    • Matthias Steinbauer, M.D. · Sub investigator
    • Torleif Trydal, M.D. · Sub investigator
    • Sten Rasmussen, M.D. · Sub investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01955577
Lead sponsor
Northern Orthopaedic Division, Denmark
Responsible party
Sponsor
First posted
Oct 7, 2013
Start date
Apr 2015
Primary completion
Dec 2015 (estimated)
Completion
Dec 2016 (estimated)
Last update
Apr 10, 2015

Study contacts

Christian Cavallius, M.D.
Contact
christian.cavallius@rn.dk
Juozas Petruskevicius, M.D., Ph.D.
Contact
juope@rn.dk
99 32 52 40 ext. 45
Tine L. Bennedsen, M.D.
principal investigator · Aalborg University Hospital, Denmark

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion